TITLE

Quantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry

AUTHOR(S)
Collins, Lisamarie A.; Olivier, Michael
PUB. DATE
January 2010
SOURCE
Proteome Science;2010, Vol. 8, p42
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Lipoproteins are complex, globular molecules which play essential roles in the transport and metabolism of cholesterol. Their implication in the development of cardiovascular diseases, such as atherosclerosis, has sustained a great deal of interest in these particles. Their various functions, and their contribution to the development of atherosclerosis, are often attributed to their protein constituents, which vary greatly among the different lipoprotein classes. Recent advances in the field of mass spectrometry have provided insight into the array of proteins associated with low-density lipoproteins (LDLs) and, even more so, with high-density lipoproteins (HDLs). Plasma and serum are the most commonly used samples for the analysis of lipoproteins. Although these lipoprotein sources are unique, it was our goal to determine whether or not their inherent differences would ultimately affect a quantitative analysis of the LDL and HDL proteomes. To this end, we isolated LDL and HDL fractions with fast protein liquid chromatography-size exclusion chromatography (FPLC-SEC) from both human plasma and serum samples from the same individuals. After delipidating these samples, we performed a quantitative proteomic analysis to compare the lipoprotein-associated proteins derived from both plasma and serum. Results: Although the primary differences between the samples are found in fibrinogen proteins which are removed from serum, it of interest to note that, with respect to LDL-associated proteins, apolipoproteinB-100 was found at significantly higher levels in serum samples. Complement component 3 was found at significantly higher levels in serum-derived HDL fractions. Both of these proteins are known LDL- and HDL-associated proteins, respectively. Conclusion: Overall, the results from our study indicate that both plasma and serum samples are equally suited for proteomic studies, and provide similar results. These findings are particularly important for studies profiling proteomic differences in lipoprotein particle composition in a variety of disease conditions, including cardiovascular disease.
ACCESSION #
53440372

 

Related Articles

  • High Density Lipoprotein and it's Dysfunction. Eren, Esin; Yilmaz, Necat; Aydin, Ozgur // Open Biochemistry Journal;2012, Vol. 6, p78 

    Plasma high-density lipoprotein cholesterol(HDL-C) levels do not predict functionality and composition of high-density lipoprotein(HDL). Traditionally, keeping levels of low-density lipoprotein cholesterol(LDL-C) down and HDL-C up have been the goal of patients to prevent atherosclerosis that...

  • New Methodology and Approaches to Intracellular Lipid Transport in Atherosclerosis and Cardiovascular Disease. Roufogalis, Basil D.; Grewal, Thomas // Current Pharmaceutical Biotechnology;Feb2012, Vol. 13 Issue 2, p276 

    No abstract available.

  • The not-so-simple HDL story: A new era for quantifying HDL and cardiovascular risk? Heinecke, Jay W // Nature Medicine;Sep2012, Vol. 18 Issue 9, p1346 

    The article offers information regarding quantification of high density lipoproteins (HDL) and cardiovascular diseases. It mentions the risks of high levels of low-density lipoprotein (LDL) which promotes atherosclerosis by delivering cholesterol in the artery walls. It discusses the linking of...

  • Cholesteryl ester transfer protein and its inhibition. Weber, Olaf; Bischoff, Hilmar; Schmeck, Carsten; Böttcher, Michael-Friedrich // Cellular & Molecular Life Sciences;Sep2010, Vol. 67 Issue 18, p3139 

    Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that facilitates the transfer of cholesteryl esters from the atheroprotective high density lipoprotein (HDL) to the proatherogenic low density lipoprotein cholesterol (LDL) and very low density lipoprotein cholesterol (VLDL)...

  • Cholesterol Quiz. Zipes, Douglas P. // Saturday Evening Post;Mar/Apr2011, Vol. 283 Issue 2, p78 

    The article discusses cholesterol, and covers topics such as cholesterol's production in the liver, cell health in the body, and the difference between low-density lipoprotein (LDL) and high-density lipoprotein.

  • Taking Three To Heart: Know The Cholesterol Three.  // Tennessee Tribune;10/28/2010, Vol. 21 Issue 43, p11B 

    The article offers tips on how to raise the high-density lipoprotein levels (HDL) and decrease the adverse effects of the low-density lipoprotein (LDL).

  • On cholesterol watch.  // Marines;Oct98, Vol. 27 Issue 10, p30 

    Discusses information about cholesterol. Explanations on low density lipoprotein (LDL) and high density lipoprotein (HDL); Sources of cholesterol.

  • LDL i HDL holesterol u angiografski dokazanoj koronarnoj bolesti. Halilovic, Enes; Kabil, Emir; Ljuca, Farid; Nuhbegovic, Sabina; Berbic, Selma; Halilovic, Ejub // Medicinski Arhiv;2007 Supplement, Vol. 61 Issue 2, p7 

    The retrospective study included 250 patients, treated at Clinic for cardiovascular diseases of Tuzla Clinical center, between 30.08.2003. and 15.11.2004. In the coronary disease group there were 145 men, 55 women, with diagnosed coronary artery stenosis of 50% or more. The control group had 150...

  • Implementation Strategies to Improve Non-HDL-Cholesterol Goal Attainment. Virani, Salim S. // Texas Heart Institute Journal;2012, Vol. 39 Issue 2, p228 

    The article discusses the strategies for improving non-high-density-lipoprotein cholesterol (non-HDL-C) goal attainment. It was suggested that non-HDL-C is a better cardiovascular risk marker compared with low-density-lipoprotein cholesterol (LDL-C). The reasons for lower non-HDL-C goal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics